Ignite Creation Date:
2025-12-24 @ 4:55 PM
Ignite Modification Date:
2026-02-03 @ 3:14 PM
Study NCT ID:
NCT05740150
Status:
UNKNOWN
Last Update Posted:
2023-02-22
First Post:
2023-02-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Central Line-associated Bloodstream Infection Prevention Using TauroLock-Hep100 in Pediatric Oncology Patients.
Sponsor:
Princess Maxima Center for Pediatric Oncology
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Central Line-associated Bloodstream Infection (CLABSI) | View |